Kyntra Bio, Inc. (KYNB)
8.55
+0.06
(+0.71%)
USD |
NASDAQ |
Sep 04, 16:00
8.55
0.00 (0.00%)
After-Hours: 20:00
Kyntra Bio Cash and Short Term Investments (Annual) : 88.98M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 88.98M |
| December 31, 2024 | 50.48M |
| December 31, 2023 | 203.45M |
| December 31, 2022 | 422.01M |
| December 31, 2021 | 405.19M |
| December 31, 2020 | 686.54M |
| December 31, 2019 | 533.76M |
| Date | Value |
|---|---|
| December 31, 2018 | 621.40M |
| December 31, 2017 | 735.72M |
| December 31, 2016 | 253.18M |
| December 31, 2015 | 181.17M |
| December 31, 2014 | 179.82M |
| December 31, 2013 | 122.81M |
| December 31, 2012 | 39.89M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Vericel Corp. | 137.50M |
| Capricor Therapeutics, Inc. | 318.13M |
| ARS Pharmaceuticals, Inc. | 244.99M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |